ADOR Diagnostics receives its first commercial order for NATlab

Under the terms of an agreement, BATM Advanced Communications’ affiliate, ADOR Diagnostics, will distribute its molecular diagnostics platform called NATlab after the first half of this year, following a recent order from a leading Italian provider of molecular biology and genomics products.

ADOR’s ground-breaking NATlab, which has been designed specifically for use in hospital laboratories and at the point of care, uses DNA sampling to diagnose fungal, bacterial or viral infections, between a quarter of an hour to an hour and a half. Subsequently, it was suggested that the platform for molecular diagnostics will enable medical practitioners to provide more effective and rapid treatment.

Chief Executive Officer at BATM, Dr Zvi Marom, stated: “We are delighted that Ador has received the first commercial order for the NATlab system, which is an important milestone. Meningitis is a leading infectious cause of childhood death, and speed of identification and treatment is vital. We are proud that our rapid sample to answer solution will help medical practitioners to quickly and efficiently diagnose the specific infection and administer the required treatment. We believe NATlab will transform the infectious disease diagnostics market and we have already received extremely positive feedback and significant interest from several leading medical institutions that are testing the solution. Ador is also working alongside prominent academic and research institutions, including in the UK to develop more panels for the identification of further diseases. We look forward to reporting on Ador’s progress.”